版本:
中国

BRIEF-Allergan partners with Target Pharmasolutions to advance NASH research

April 20 Allergan Plc

* Allergan partners with Target Pharmasolutions to advance NASH research

* Allergan-Target-Nash is 5-year longitudinal observational study, looks at patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐